Corvus Pharmaceuticals, Inc. (CRVS) — DEFA14A Filings
All DEFA14A filings from Corvus Pharmaceuticals, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Corvus Pharma Files Proxy Statement
— Apr 25, 2025 Risk: low
Corvus Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 25, 2025. This filing is related to the company's proxy materials, likely for
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX